v3.26.1
Revenues (Tables)
 3 Months Ended
Mar. 31, 2026
Revenue from Contract with Customer [Abstract]  
Schedule of net product revenues by product
The Company’s net revenues consisted of the following for the three months ended March 31, 2026 and 2025:
Three months ended March 31,
20262025
Products:
Sancuso2,928,634 2,256,294 
Vibativ2,118,295 1,378,066 
Talicia1,916,481 — 
Kristalose981,483 3,484,310 
Caldolor965,564 1,307,439 
Acetadote51,981 151,651 
Vaprisol517 (600)
Omeclamox-Pak1 (5,387)
RediTrex(489)(347)
Other revenue168,850 3,141,629 
Total net revenues$9,131,317 $11,713,055